Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 4/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PRNP | P04156 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8182334 | 0.98 | PARP1 (0.42) | PARP1ARALDH1A1CYP2C9HPGD | |
| Resorcinol SCHEMBL10620240 | 0.85 | PARP1 (0.43) | PARP1ALDH1A1HPGDHCAR2BCL2L1 | |
| SCHEMBL28223167 | 0.80 | DAO (0.41) | RXFP1DAO | |
| SCHEMBL1203617 | 0.78 | LTB4R (0.50) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL6713000 | 0.77 | PARP1 (0.42) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL9525223 | 0.77 | LTB4R (0.49) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL21531465 | 0.77 | CALM1 (0.46) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL5600491 | 0.77 | HTR2C (0.45) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL305311 | 0.77 | PARP1 (0.42) | PARP1ARALDH1A1CYP2C9HPGD | |
| SCHEMBL17296040 | 0.76 | PARP1 (0.43) | PARP1ALDH1A1HPGDBCL2L1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119101410-A | Plasma cutting protection liquid and application thereof | 浙江奥首材料科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-112021051-A | Kiwi root rot control method | 台州市农业科学研究院 | 2020-12-04 | — | — | CN | claimed |
| CN-119101410-A | Plasma cutting protection liquid and application thereof | 浙江奥首材料科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-11834553-B2 | Alkoxylation methods | NEKTAR THERAPEUTICS (US) | 2023-12-05 | — | — | US | disclosed |
| US-11672776-B2 | Multi-arm polymeric alkanoate conjugates | NEKTAR THERAPEUTICS (US) | 2023-06-13 | — | — | US | disclosed |
| US-20220079936-A1 | MULTI-ARM POLYMER PRODRUGS | NEKTAR THERAPEUTICS (US) | 2022-03-17 | — | — | US | disclosed |
| US-20210024693-A1 | ALKOXYLATION METHODS | NEKTAR THERAPEUTICS | 2021-01-28 | — | — | US | disclosed |
| CN-112021051-A | Kiwi root rot control method | 台州市农业科学研究院 | 2020-12-04 | — | — | CN | disclosed |
| US-10463659-B2 | Multi-arm polymer prodrugs | NEKTAR THERAPEUTICS (US) | 2019-11-05 | — | — | US | disclosed |
| EP-3498754-A1 | ALKOXYLATION METHODS | Nektar Therapeutics (US) | 2019-06-19 | — | — | EP | disclosed |
| EP-2501413-B1 | ACID SALT FORMS OF POLYMER-DRUG CONJUGATES | NEKTAR THERAPEUTICS (US) | 2019-03-27 | — | — | EP | disclosed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994007511-A1 | ANTIBODIES DETECTING STROMELYSIN CLEAVAGE PRODUCTS | MERCK & CO., INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| EP-0486478-A2 | Renin-inhibiting peptides | THE UPJOHN COMPANY (US) | 1992-05-20 | — | — | EP | disclosed |
| US-4880781-A | HYPOTENSIVE AGENTS | THE UPJOHN COMPANY (US) | 1989-11-14 | — | — | US | disclosed |
| WO-1988004665-A1 | A NEW PERTUSSIS TOXIN DERIVED POLYPEPTIDE AND APPLICATIONS THEREOF | TRION FORSKNING- OCH UTVECKLINGS AKTIEBOLAG (SE) | 1988-06-30 | — | — | WO | disclosed |
| WO-1988002754-A1 | NEW PEPTIDES AND APPLICATIONS THEREOF | TRION FORSKNING- OCH UTVECKLINGS AKTIEBOLAG (SE) | 1988-04-21 | — | — | WO | disclosed |
| WO-1987007150-A1 | RECEPTOR-TARGETED DRUG DELIVERY SYSTEMS | THE JOHNS HOPKINS UNIVERSITY (US) | 1987-12-03 | — | — | WO | disclosed |
| EP-0054862-B1 | SUBSTITUTED DIPEPTIDES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE INHIBITION OF ENKEPHALINASE | SCHERING CORPORATION (US) | 1985-11-27 | — | — | EP | disclosed |
| EP-0054862-A1 | Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase | SCHERING CORPORATION (US) | 1982-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672776-B2 | Multi-arm polymeric alkanoate conjugates | ALK, ALKBH3, PAICS | PARP1 55/4885AR 648/4885ALDH1A1 74/4885 |
| US-10463659-B2 | Multi-arm polymer prodrugs | PAICS, CD38, ENTPD1 | PARP1 21/4885AR 2328/4885ALDH1A1 250/4885 |
| US-20210024693-A1 | ALKOXYLATION METHODS | ALK, ALKBH3, SLC10A1 | PARP1 1347/4885AR 483/4885ALDH1A1 282/4885 |
| US-11834553-B2 | Alkoxylation methods | ALK, ALKBH3, SLC10A1 | PARP1 1347/4885AR 483/4885ALDH1A1 282/4885 |
| US-20220079936-A1 | MULTI-ARM POLYMER PRODRUGS | PAICS, CD38, ENTPD1 | PARP1 21/4885AR 2328/4885ALDH1A1 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.